labetalol has been researched along with Neoplasms in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol is an alpha- and beta-blocking agent commonly used in anti-hypertensive therapy." | 5.27 | Analgesic effect of peridural labetalol in the treatment of cancer pain. ( Fanzago, E; Gagliardi, M; Margaria, E; Palieri, L; Treves, S, 1983) |
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| "Labetalol is an alpha- and beta-blocking agent commonly used in anti-hypertensive therapy." | 1.27 | Analgesic effect of peridural labetalol in the treatment of cancer pain. ( Fanzago, E; Gagliardi, M; Margaria, E; Palieri, L; Treves, S, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| Margaria, E | 1 |
| Gagliardi, M | 1 |
| Palieri, L | 1 |
| Treves, S | 1 |
| Fanzago, E | 1 |
1 review available for labetalol and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
1 other study available for labetalol and Neoplasms
| Article | Year |
|---|---|
Analgesic effect of peridural labetalol in the treatment of cancer pain.
Topics: Analgesics; Ethanolamines; Female; Humans; Injections; Labetalol; Neoplasms; Pain; Subdural Space | 1983 |